Bristol Myers signs deal with Janux on T cell engager for $50M upfront
Bristol Myers signs deal with Janux on T cell engager for $50M upfront
Contenu indisponible. Consultez la source originale.
Bristol Myers signs deal with Janux on T cell engager for $50M upfront
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.